ANRO: Alto Neuroscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 84.15
Enterprise Value ($M) -87.40
Book Value ($M) 165.05
Book Value / Share 6.12
Price / Book 0.51
NCAV ($M) 156.97
NCAV / Share 5.82
Price / NCAV 0.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.66
Return on Equity (ROE) -0.81

Liquidity (mrq)
Quick Ratio 13.09
Current Ratio 13.09

Balance Sheet (mrq) ($M)
Current Assets 183.53
Assets 191.61
Liabilities 26.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
9 days ago 13G/A Ra Capital Management, L.p.
9 days ago 13G/A Point72 Asset Management, L.P.
02-12 13G/A Fmr Llc
11-14 13G Etkin Amit 5.40
11-08 13G BlackRock, Inc. 5.40 0.00
2024-02-09 13G Falcon Edge Capital, LP 13.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 28,864 119,468 24.16
2025-02-20 54,785 135,048 40.57
2025-02-19 56,376 169,765 33.21
2025-02-18 84,593 218,420 38.73

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ADCT – ADC Therapeutics SA ANVS – Annovis Bio, Inc.
BHC – Bausch Health Companies Inc.


Financial data and stock pages provided by
Fintel.io